Association between changes in prices and out-of-pocket costs for brand-name clinician-administered drugs.
Hussain S LalaniMassimilano RussoRishi J DesaiAaron S KesselheimBenjamin N RomePublished in: Health services research (2024)
From 2009 to 2018, prices and out-of-pocket costs for brand-name clinician-administered drugs increased, but these were not directly related for individual drugs. This may be due to changes to insurance benefit design and private insurer drug reimbursement rates.